psychedelics investing NeonMind Biosciences: Using Psychedelics as Treatment for Mental Health Disorders and Weight Management
Psychedelics Investing NeonMind To Improve Patient Care and Data Management by Adopting Digital Platform for Ketamine Treatments in Preparation of Opening Its Inaugural Specialty Mental Health Clinic
Psychedelics Investing NeonMind Engages Leading Digital Platform for Medical Education and Adoption of Ketamine Treatments in Preparation of Opening its Inaugural Specialty Mental Health Clinic
Psychedelics Investing NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
Psychedelics Investing NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga
Psychedelics Investing NeonMind Announces Positive Preclinical Results Demonstrating the Efficacy of Psilocybin in Reducing Weight Gain in Obese Animal Subjects
Psychedelics Investing NeonMind Files New Provisional Patent Application Covering Novel Mechanism of Weight Loss
Psychedelics Investing NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments
